Your browser doesn't support javascript.
loading
Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial.
Deutsch, E; Lemanski, C; Pignon, J P; Levy, A; Delarochefordiere, A; Martel-Lafay, I; Rio, E; Malka, D; Conroy, T; Miglianico, L; Becouarn, Y; Malekzadeh, K; Paris, E; Juzyna, B; Ezra, P; Azria, D.
Affiliation
  • Deutsch E; Department of Radiotherapy, Institut Gustave-Roussy, Villejuif.
Ann Oncol ; 24(11): 2834-8, 2013 Nov.
Article in En | MEDLINE | ID: mdl-24026540

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Anus Neoplasms / Drug-Related Side Effects and Adverse Reactions / Neoplasm Recurrence, Local Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2013 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 2_ODS3 Database: MEDLINE Main subject: Anus Neoplasms / Drug-Related Side Effects and Adverse Reactions / Neoplasm Recurrence, Local Type of study: Clinical_trials / Guideline Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Oncol Year: 2013 Document type: Article